#40 - Three Breakthroughs: Brain-Computer Interfaces, Advanced Neural Networks, and Ozempic Trade Update
from Tech Optimist: An Alumni Ventures Podcast Hosted by Alumni Ventures
In the latest episode of the AV Tech Optimist podcast, 'Three Breakthroughs' segment, Mike Collins and Mike Peri explore three transformative technologies set to reshape our health. They delve into Neuralink's brain-machine interfaces, which promise to revolutionize neurological treatments and enhance cognitive capabilities. The discussion also covers advancements in artificial intelligence through deep neural networks, pushing the boundaries of machine learning. Additionally, they discuss the widespread impact of GLP-1 drugs on managing diabetes and obesity, with significant implications for public health. Tune in to learn how these innovations are at the forefront of medical and technological progress. To Learn More: Alumni Ventures (AV) AV LinkedIn AV Deep Tech Fund Tech Optimist Speakers: Mike Collins - Host Mike Peri- Guest Chapters: (00:00) - Intro (04:55) - Brain-Computer Interfaces (21:20) - Advanced Neural Networks (32:46) - Ozempic Trade Update (49:14) - Closing Legal Disclosure: https://av-funds.com/tech-optimist-disclosures
Embed this episode
Chapters
No transcript yet.